Investors

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
Dec 17, 2010 goldstein joseph l Director Automatic Sell 5,281 32.00
Dec 16, 2010 goldstein joseph l Director Option Execute 10,000 15.01
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Nov 23, 2010 goldstein joseph l Director Option Execute 10,000 15.01 - 18.80
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Oct 5, 2010 goldstein joseph l Director Automatic Sell 3,152 28.40
Oct 4, 2010 goldstein joseph l Director Option Execute 10,000 18.80
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
May 17, 2010 goldstein joseph l Director Sell 400 28.06
May 14, 2010 goldstein joseph l Director Option Execute 5,000 25.43
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
Aug 11, 2008 goldstein joseph l Director Acquisition (Non Open Market) 3,000 n/a
Jan 22, 2008 goldstein joseph l Director Option Execute 5,000 7.66
Jan 22, 2008 goldstein joseph l Director Automatic Sell 5,000 25.00
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Showing 301-320 of 873 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)